Pathology

Pathology/C/22

Pulmonary diseases of vascular origin — pulmonary embolism, hemorrhage, and infarction

肺血管原性疾患(肺塞栓・肺出血・肺梗塞)

タグ
High-yield / ポイント

Pulmonary Embolism (PE)

Source

  • Blood clots in large pulmonary arteries are almost always embolic in origin
  • >95% originate from deep veins (femoral, iliac, popliteal)
  • Minority from periprostatic/parametric vein plexus

Risk factors for deep venous thrombosis

  • Prolonged bedrest
  • Surgery (especially knee/hip orthopedic)
  • Severe trauma (burns, fractures)
  • Congestive heart failure
  • Disseminated cancer
  • Primary hypercoagulability (e.g. Factor V Leiden)

Consequences

Two key consequences of embolic pulmonary arterial occlusion:

  1. ↑ Pulmonary artery pressure (blockage + vasospasm)
  2. Ischemia of downstream lung parenchyma

Occlusion of major vessel:

  • ↑ Pulmonary arterial pressure
  • ↓ Cardiac output
  • Right-sided heart failure
  • Hypoxemia (atelectasis perfusion, ↓ CO, possible right-to-left shunt through patent foramen ovale)

Smaller vessel occlusion: less catastrophic; may be clinically silent

Hemorrhagic pulmonary infarct occurs only if bronchial circulation is compromised (e.g. CHF) or bronchial circulation is impaired


Morphology

Large emboli (saddle embolus at bifurcation):

  • Sudden death from hypoxia or acute cor pulmonale; no time for morphological changes

Medium/small emboli:

  • Obstruct small/medium pulmonary arteries → lung parenchyma maintained; but ischemic endothelial damage → pulmonary hemorrhage

Infarction (if compromised cardiovascular status):

  • Usually affects lower lobes
  • Shape: wedge-shaped, apex pointing towards hilus
  • Evolution:
    • Early: red-blue hemorrhagic areas
    • After 48 hrs: lysis begins → infarct pales → red-brown (hemosiderin)
    • Final stage: fibrous replacement from margins → whitish scar
  • Histology: coagulative necrosis with hemorrhage

Clinical Features

  • 60–80% of pulmonary emboli are clinically silent (small; rapid fibrinolysis)
  • Large emboli (60%): sudden death, acute right-sided heart failure (acute cor pulmonale), cardiovascular collapse (shock)
  • Recurrent multiple emboli (<3%): pulmonary hypertension, chronic cor pulmonale, pulmonary vascular sclerosis, progressive dyspnea

Treatment / Prophylaxis

  • Anticoagulation for high-risk patients
  • Thrombolytic therapy for massive PE
  • Elastic stockings
  • Pneumatic calf compression
  • Isometric leg exercises
  • Early ambulation (post-op, post-partum)

💡 High-yield: PE → >95% from DVT; saddle embolus → sudden death/acute cor pulmonale. Infarct = wedge-shaped, lower lobe; red-blue → red-brown → white scar. 60–80% clinically silent. Recurrent emboli → chronic cor pulmonale. Risk factors: Virchow’s triad (stasis, hypercoag, endothelial injury).